Skip to content
Abivax
EN
FR
About Abivax
Our Mission
Company History
Our Leadership
Contact Us
Our Science
Novel MOA
Obefazimod
Our Research
Our Pipeline
Publications
Investors
Overview
Press Releases
News
Share Price
Investor Documents
General Meeting
Corporate Presentation
EN
FR
News & Events
Press Coverage
2023
2022
2021
2020
2019
Boursier.com
September 2, 2020
Abivax fait le point sur l’efficacité et la tolérance d’ABX464
BioWorld
September 2, 2020
In the clinic for Sept. 2, 2020
Bloomberg Law
August 21, 2020
Bolsonaro’s Chloroquine Believers Hamstring Drugmakers in Brazil
RTL
August 12, 2020
Coronavirus : quels sont les traitements les plus prometteurs ?
Pharmabiz.com
July 4, 2020
Abivax initiates phase 2b/3 study of ABX464 to treat COVID-19
1
…
4
5
6
7
8
…
25
